KCI Announces Investor and Analyst Meeting on September 17

Kinetic Concepts, Inc. (NYSE:KCI), a leading global advanced wound care and therapeutic surfaces company, today announced details of its Analyst Day event on September 17, 2007 at the St. Regis Hotel in New York City. Catherine Burzik, President and CEO of KCI will host the event along with other key members of the senior leadership team. The event will include a comprehensive update on the company’s business and growth strategies as well as a review of KCI’s research and development initiatives. The opening presentation will begin promptly at 10:30 a.m. EDT. The keynote speaker for the event will be Dr. William Ennis, who is the president-elect and a founding board member for the Association for the Advancement of Wound Care (AAWC) and a key opinion leader in the field of advanced wound healing. Other physician panelists are scheduled to include Dr. Todd Rasmussen, whose pioneering work has been instrumental in reducing infection in combat injuries, Dr. Grant Bochicchio, a leading trauma surgeon and Associate Professor of Surgery and Director of Clinical and Outcomes Research for the R. Adams Cowley Shock Trauma Center at the University of Maryland Medical Center, and Dr. David Armstrong, who is Professor of Surgery at Rosalind Franklin University of Medicine and Science in Chicago and director of the renowned Center for Lower Extremity Ambulatory Research (CLEAR). The event will feature demonstrations of KCI’s next generation Info-V.A.C.® and Acti-V.A.C.® Therapy Systems, and will conclude with a question and answer session with the KCI leadership team. Event Registration: Pre-registration is required and analysts and investors may register for the event on-line from the Investor Relations page of KCI’s web site at www.kci1.com. Webcast: Portions of the event will be webcast by CCBN starting at 10:30 a.m. EDT, and can be accessed at the Kinetic Concepts, Inc. web site at http://www.kci1.com/investor/index.asp, by clicking on Web cast. About KCI Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care. Our advanced wound-care systems incorporate our proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy technology, which has been demonstrated clinically to help promote wound healing through unique mechanisms of action and can help reduce the cost of treating patients with serious wounds. Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility, to prevent skin breakdown and assist caregivers in the safe and dignified handling of obese patients. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings, including acute care hospitals, extended care organizations and patients' homes, both in the United States and abroad. Forward-Looking Statements This press release contains forward-looking statements, including statements regarding the clinical evidence relating to V.A.C.® Therapy and the potential impact of the launch of the Info-V.A.C.® Therapy System and customer preference. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties. All information set forth in this release is as of its date, and we undertake no duty to update this information. More information about the company is described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006 and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2007, on file with the SEC and available at the SEC’s website at www.sec.gov.